Additionally, CRISPR sgRNA targeting of UBE2N in breast cancer cell line MDA-MB-231, using three different sgRNAs, revealed similar sensitivities to CX-5461 and PDS (Fig. 2d and Table 3). The gene discussed is UBE2N; the disease is breast carcinoma.